XML 19 R6.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Series B Preferred Stock
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Retained Earnings
Series B Preferred Stock
Treasury Stock
Beginning balance, Preferred stock, shares issued (in shares) at Dec. 31, 2023     2,510,696            
Beginning balance, Common shares issued (in shares) at Dec. 31, 2023       438,230,416          
Beginning balance (in shares) at Dec. 31, 2023                 (217,886,532)
Beginning balance (in shares) at Dec. 31, 2023       220,343,884          
Beginning balance at Dec. 31, 2023 $ 1,880,797   $ 251,070 $ 87,647 $ 1,148,689 $ (75,104) $ 3,624,859   $ (3,156,364)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 289,931           289,931    
Other comprehensive loss, net of tax (2,187)         (2,187)      
Total comprehensive income 287,744                
Cash dividends declared:                  
Common Stock (24,278)           (24,278)    
Preferred Stock   $ (4,653)           $ (4,653)  
Issuance of common shares (in shares)       1,925,920          
Issuance of common shares 579     $ 385 1,359   (1,165)    
Stock-based compensation expense 13,790       13,790        
Common stock repurchased (in shares)       (1,310,723)         (1,310,723)
Common stock repurchased $ (26,639)               $ (26,639)
Shares repurchased related to employee stock-based compensation plans (in shares) (683,247)     (683,247)         (683,247)
Shares repurchased related to employee stock-based compensation plans $ (13,601)               $ (13,601)
Ending balance, Preferred stock, shares issued (in shares) at Mar. 31, 2024     2,510,696            
Ending balance, Common shares issued (in shares) at Mar. 31, 2024       440,156,336          
Ending balance (in shares) at Mar. 31, 2024                 (219,880,502)
Ending balance (in shares) at Mar. 31, 2024       220,275,834          
Ending balance at Mar. 31, 2024 $ 2,113,739   $ 251,070 $ 88,032 1,163,838 (77,291) 3,884,694   $ (3,196,604)
Beginning balance, Preferred stock, shares issued (in shares) at Dec. 31, 2024 2,500,000   2,510,696            
Beginning balance, Common shares issued (in shares) at Dec. 31, 2024 440,600,000     440,604,795          
Beginning balance (in shares) at Dec. 31, 2024 (230,200,000)               (230,222,501)
Beginning balance (in shares) at Dec. 31, 2024       210,382,294          
Beginning balance at Dec. 31, 2024 $ 2,159,920   $ 251,070 $ 88,121 1,193,753 (65,861) 4,114,446   $ (3,421,609)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 304,540           304,540    
Other comprehensive loss, net of tax 10,230         10,230      
Total comprehensive income 314,770                
Cash dividends declared:                  
Common Stock (27,466)           (27,466)    
Preferred Stock   $ (3,956)           $ (3,956)  
Issuance of common shares (in shares)       2,224,810          
Issuance of common shares 1,042     $ 445 1,992   (1,395)    
Stock-based compensation expense 13,272       13,272        
Common stock repurchased (in shares)       (1,037,391)         (1,037,391)
Common stock repurchased $ (30,756)               $ (30,756)
Shares repurchased related to employee stock-based compensation plans (in shares) (830,868)     (830,868)         (830,868)
Shares repurchased related to employee stock-based compensation plans $ (25,970)               $ (25,970)
Ending balance, Preferred stock, shares issued (in shares) at Mar. 31, 2025 2,500,000   2,510,696            
Ending balance, Common shares issued (in shares) at Mar. 31, 2025 442,800,000     442,829,605          
Ending balance (in shares) at Mar. 31, 2025 (232,100,000)               (232,090,760)
Ending balance (in shares) at Mar. 31, 2025       210,738,845          
Ending balance at Mar. 31, 2025 $ 2,400,856   $ 251,070 $ 88,566 $ 1,209,017 $ (55,631) $ 4,386,169   $ (3,478,335)